State of the ART: Applying Up-to-Date Safety and Tolerability Data to Individualize HIV Care

In this comprehensive educational program expert faculty discuss the latest updates on ART safety and tolerability issues focusing on unique populations such as pregnant women aging patients populations with cardiometabolic toxicities and transgender persons.

Share

Program Content

No activities added yet

Activities

ART-Related Weight Gain
Not Quite There: Why I Don’t Yet Switch ART in Weight Gain
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 10, 2023

2-Drug ART
Simplifying to 2-Drug ART: Safety and Tolerability Considerations
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 23, 2022

Expires: December 22, 2023

Insights on Weight Gain
Gaining Insights on ART Tolerability Challenges: A Focus on Weight Gain
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 31, 2022

Activities

Data Updates: Summer 2022
State of the ART: Safety and Tolerability Data Discussions From Summer 2022
Video
Congratulations: You achieved a completion on 04/09/2022

Released: November 03, 2022

Expires: November 02, 2023

Data Updates: CROI 2023
State of the ART: Safety and Tolerability Data Discussions From CROI 2023
Video
Congratulations: You achieved a completion on 04/09/2022

Released: May 09, 2023

Expires: May 08, 2024

Activities

HIV Treatment in Pregnancy
Safety Considerations for HIV Treatments During Pregnancy
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: August 23, 2022

Expires: August 22, 2023

Cardiometabolic Toxicities
Weight Gain and Cardiometabolic Toxicities in Patients With HIV
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: October 04, 2022

Expires: October 03, 2023

HIV ART in Aging Patients
ART Safety Considerations in Aging Patients With HIV
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: November 02, 2022

Expires: November 01, 2023

HIV ART in Transgender Individuals
Addressing ART Safety and Tolerability in Transgender Individuals
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: December 07, 2022

Expires: December 06, 2023

Q&A: HIV ART Safety Part 1
Questions Answered on ART Safety and Tolerability in Aging Patients and Populations With Cardiometabolic Toxicities
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: January 17, 2023

Expires: January 16, 2024

Q&A: HIV ART Safety Part 2
Questions Answered on ART Safety and Tolerability in Pregnant People and Transgender Individuals
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: February 23, 2023

Expires: February 22, 2024

Activities

ART Safety and Tolerability
Comprehensive Slides on State of the ART: Applying Up-to-Date Safety and Tolerability Data to Individualize HIV Care
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 28, 2022

Faculty

cover img faculity

Jean Rene Anderson, MD

Professor
Department of Gynecology and Obstetrics
Johns Hopkins University
Director, Johns Hopkins HIV Women’s Health Program
Johns Hopkins Medical Institutions
Baltimore, Maryland

cover img faculity

Jill Blumenthal, MD, MAS

Associate Professor of Medicine
Infectious Diseases and Global Public Health
University of California, San Diego
San Diego, California

cover img faculity

Marta Boffito, MD, PhD, FRCP, MBA

Consultant Physician
Clinical Director
HIV, Sexual and Gender Health, Dermatology
Chelsea and Westminster Hospital NHS Foundation Trust
Imperial College London
London, United Kingdom

cover img faculity

Jennifer Cocohoba, PharmD, AAHIVP

Professor of Clinical Pharmacy
Department of Clinical Pharmacy
University of California San Francisco School of Pharmacy
San Francisco, California

cover img faculity

Joseph J. Eron, Jr., MD

Professor of Medicine, School of Medicine
Herman and Louise Smith Distinguished Professor
Chief, Division of Infectious Diseases
Director, Clinical Core, UNC Center for AIDS Research
Adjunct Professor of Epidemiology
Gillings School of Global Public Health
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

cover img faculity

Julian Falutz, MD, FRCPC

Associate Professor of Medicine
Department of Medicine
McGill University School of Medicine
Director
Comprehensive HIV and Aging Initiative
Chronic Viral Illness Service
McGill
Montreal, Quebec, Canada

cover img faculity

Eric K. Farmer, PharmD, BCPS, AAHIVP

HIV Clinical Pharmacist
LifeCare Clinic
Indiana University Health
Indianapolis, Indiana

cover img faculity

Priscilla Y. Hsue, MD

Professor of Medicine
University of California at
San Francisco
San Francisco General Hospital
San Francisco, California

cover img faculity

David Koren, PharmD, MPH, AAHIVP, FIDSA

Adjunct Clinical Professor
Temple University School of Pharmacy
Clinical Pharmacist Specialist
Temple University Health System
Philadelphia, Pennsylvania

cover img faculity

Jens D. Lundgren, MD, DMSc

Professor
Rigshospital, University of Copenhagen
Director
Centre of Excellence for Health, Immunity and Infection (CHIP)
Rigshospital, University of Copenhagen
Copenhagen, Denmark

cover img faculity

Aadia I. Rana, MD

Professor of Medicine
Division of Infectious Diseases
University of Alabama at Birmingham Heersink School of Medicine
Birmingham, Alabama

cover img faculity

William R. Short, MD, MPH, FIDSA

Associate Director of the HIV Clinical Trials Unit
Associate Professor of Medicine
Division of Infectious Diseases
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

cover img faculity

Darcy Wooten, MD, MS

Professor of Medicine
Associate Chief for Medical Education
Division of Infectious Diseases
John T. Milliken Department of Medicine
Washington University School of Medicine in St Louis
St Louis, Missouri

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from Janssen Therapeutics, Division of Janssen Products, LP and ViiV Healthcare.

Janssen Therapeutics, Division of Janssen Products, LP

ViiV Healthcare